Linked databases 9 · 미국 EPA 화학물질 DB, 미국 EPA CompTox, 미국 FDA 물질 등록(GSRS), 미국 FDA 물질 식별번호(UNII) +5
Definition
미국 FDA 물질 등록 · UNII 9W0D6VB8FH · 등록명 LITHIUM MYRISTATE · 단일 화학물질
Source: 미국 FDA 물질 식별번호(UNII)
Names & identifiers
LITHIUM MYRISTATEINCITetradecanoic acid, lithium salt동의어
- CAS No.chemical registry number
- 20336-96-3
- EC No.EU chemical inventory number
- 243-743-8
- DTXSIDUS EPA chemical ID
- DTXSID9066596
- DTXCIDUS EPA compound ID
- DTXCID5036264
- IUPAC
- Lithium tetradecanoate
- Molecular formula
- C14H27LiO2
- Molecular weight
- 234.31 g/mol
Cosmetic roles
물과 기름을 섞어 유지함SURFACTANT - EMULSIFYING
Safety & regulatory references
국내 유독물 GHS 분류 없음 · 기존화학물질
Source: 한국환경공단 유독물 GHS 정보
Other restriction: ban substances that deplete the ozone layer
Source: EU CosIng 성분 목록
What products actually use it for
미국 EPA에 이 성분을 신고한 제품 5건의 용도입니다. 화장품 밖의 제품도 포함되어 있어, 위쪽 몇 줄이 이 성분의 주된 쓰임으로 읽힌다는 뜻입니다.
- 결정 조절2
- 안정화제1
- 공정 보조1
- 유화제1
Source: 미국 EPA CompTox
Irritation and sensitisation studies
피부 시험 8건 · 눈 시험 3건이 기록되어 있습니다.
중간으로 분류1건낮음으로 분류8건
시험마다 결론이 갈립니다(가장 많은 결론의 비중 11%). 이 성분이 자극적이라고 단정할 수 없다는 뜻입니다. 원료 자체를 시험한 기록이고, 완제품에 든 농도에서의 자극성과는 다릅니다.
시험 11건 전부 보기
- Not likely to be sensitizing
skin sensitisation: in vivo (non-LLNA) · Screening · equivalent or similar to OECD Guideline 406 (Skin Sensitisation) Magnusson and Kligman - Not likely to be sensitizing
skin sensitisation: in vivo (non-LLNA) · Screening · equivalent or similar to OECD Guideline 406 (Skin Sensitisation) Magnusson and Kligman (1969) - Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) equivalent or similar to - Not likely to be sensitizing
skin sensitisation: in vivo (LLNA) · Screening · according to OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay) according to EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay) - Studies Indicate No Significant Irritation
skin corrosion: in vitro / ex vivo · Screening · other guideline: OECD Guideline 439 (In Vitro Skin Irritation) according to - Moderate or Mild Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) equivalent or similar to - Not likely to be sensitizing
skin sensitisation: in vivo (non-LLNA) · Screening · equivalent or similar to OECD Guideline 406 (Skin Sensitisation) - Ambiguous
skin corrosion: in vitro / ex vivo · Screening · EU Method B.40 (In Vitro Skin Corrosion: Transcutaneous Electrical Resistance Test (TER)) according to other guideline: OECD GUIDELINE FOR THE TESTING OF CHEMICALS 431 according to - Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) equivalent or similar to - Severe Irritation
eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) according to - Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) according to EU Method B.5 (Acute Toxicity: Eye Irritation / Corrosion) according to
Source: 미국 EPA CompTox